Cargando…
Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring
Fibrillary glomerulonephritis (FGN) is a rare glomerular disease characterized by glomerular deposition of randomly arranged non-amyloid fibrils. FGN has a poor renal prognosis and its optimal treatment is a medical challenge. Rituximab therapy has recently emerged as a promising approach even thoug...
Autores principales: | Leibler, Claire, Moktefi, Anissa, Matignon, Marie, Debiais-Delpech, Céline, Oniszczuk, Julie, Sahali, Dil, Cohen, José L., Grimbert, Philippe, Audard, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262590/ https://www.ncbi.nlm.nih.gov/pubmed/30423930 http://dx.doi.org/10.3390/jcm7110430 |
Ejemplares similares
-
Monotypic plasma cell interstitial nephritis as the only clinical manifestation in a patient with previously undiagnosed indolent multiple myeloma: A case report
por: Attias, Philippe, et al.
Publicado: (2016) -
CD44 staining in parietal epithelial cells and early steroid response in patients with minimal change disease
por: Morel, Antoine, et al.
Publicado: (2023) -
Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
por: Sainz-Prestel, Valeria, et al.
Publicado: (2013) -
Glomerulonephritis With Isolated C3 Deposits as a Manifestation of Subtotal Factor I Deficiency
por: Boudhabhay, Idris, et al.
Publicado: (2019) -
Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis
por: Bouachi, Khedidja, et al.
Publicado: (2018)